Clinical Trial Update: Inhaled Polymyxin E to Prevent VAP [NA]

View source ↗

Summary

Clinical trial update on inhaled polymyxin E for preventing ventilator-associated pneumonia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Polymyxin E (inhaled) (polymyxin E)

Snippet

Sponsor: Southeast University, China | Conditions: Ventilator-Associated Pneumonia (VAP), Inha'le'd | NA | Status: NOT_YET_RECRUITING